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Patients referred to the hospital with sympto-
matic peripheral arterial disease (PAD) often have
symptomatic or asymptomatic manifestations of ath-
erosclerosis elsewhere in the vascular system,
because atherosclerosis is a generalized and progres-
sive process. The risk of premature death in patients
who have PAD is three times the risk in subjects
without the disease.1 Approximately 50% of the
deaths are caused by myocardial ischemia, and 15%
are caused by stroke.2 The presence of co-existing
cerebrocardiovascular disease increases mortality in
patients who have PAD.2-5
We investigated the prevalence of internal carotid
artery stenosis (ICAS) in patients who had PAD and
who were not yet known to have carotid disease and
who never had sustained (transient) cerebral
ischemia. We also investigated which patient charac-
teristics were associated with the presence of ICAS.
PATIENTS AND METHODS
Patients. We used data from the first 600 patients
enrolled in the Second Manifestations of ARTerial dis-
ease (SMART) study, a single-center, prospective
cohort study of patients referred to the University
Medical Center, Utrecht, The Netherlands, for the
first time with a manifestation of cardiovascular dis-
ease (PAD, ICAS, abdominal aortic aneurysm, tran-
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Purpose: The prevalence of asymptomatic internal carotid artery stenosis (ICAS) in
patients with peripheral arterial disease (PAD) and characteristics that are associated
with ICAS were studied. 
Methods: We used data from the first 600 patients enrolled in the Second Manifestations
of ARTerial disease (SMART) study, a single-center, prospective cohort study among
patients referred with a manifestation of cardiovascular disease, diabetes mellitus, hyper-
tension, or hyperlipidemia. Included in the analysis were 162 patients with PAD or a his-
tory of PAD, who were not known to have ICAS at the time of referral and who had no
history of cerebrovascular symptoms or previous carotid endarterectomy. ICAS was
detected with duplex scanning and defined as a peak systolic velocity more than 150
cm/s (diameter reduction 50% or higher) on at least one side. Cardiovascular risk fac-
tors were measured. Logistic regression analysis was performed to investigate associa-
tions between these characteristics and ICAS. 
Results: The prevalence of previously unknown ICAS was 14%. A patient age of 67 years
or older, body weight of 68 kg or less, and diastolic blood pressure of 75 mm Hg or
lower were independently associated with ICAS. 
The prevalence of ICAS in patients with one of these characteristics (38% of the patients)
was 8%, in those with two characteristics (21% of the patients) was 32%, and in those
with three characteristics (6% of the patients) was 50%. 
Conclusions: The prevalence of ICAS increases as much as 50% in patients who have PAD
and the risk indicators of an age of 67 years or older, a body weight of 68 kg or less,
and a diastolic blood pressure of 75 mm Hg or lower, and, therefore, these characteris-
tics may be used as a means of increasing the likelihood of detecting ICAS. (J Vasc Surg
1999;30:519-25.)
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sient ischemic attack or minor stroke, diabetic foot,
angina pectoris, myocardial infarction, or renal artery
stenosis) or marked risk factors for cardiovascular dis-
ease (hyperlipidemia, diabetes mellitus, hypertension,
or renal insufficiency). Definitions of enrollment diag-
noses in the SMART study are described in Table I.
The main objectives of the SMART study are to
determine the prevalence of additional vascular dis-
ease at other sites of the vascular bed and risk factors
in patients who have a manifestation of vascular dis-
ease or risk factor and to study predictors for future
cardiovascular events in these high-risk patients.
Baseline examinations (including a questionnaire on
cardiovascular disease; measurements of height,
weight, and blood pressure; blood tests for glucose,
lipid, creatinine, and homocysteine levels; urinary
tests for microproteinuria; a resting 12-lead electro-
cardiogram; ultrasound scanning of the abdominal
aorta, kidneys, and the carotid arteries; measurements
of common carotid intima-media thickness and arter-
ial stiffness; and ankle brachial pressure indices in rest
and after exercise) were performed in all patients to
confirm the referral diagnosis, to study atherosclerosis
in other parts of the vascular system, and to screen for
risk factors. The study was approved by the ethics
committee of the University Medical Center, Utrecht,
and written informed consent was obtained from all
participants. Patients older than 79 years and those
with a terminal malignancy were not enrolled. 
Peripheral arterial disease. From the 600
patients participating in the SMART study, two
patient groups were selected for the current study.
The first group comprised patients referred because of
symptomatic PAD, whose symptoms were confirmed
by a vascular surgeon. The referral diagnosis of PAD
was confirmed with a treadmill test to obtain resting
and after-exercise ankle brachial pressure indices
(ABPI) and was defined as a resting ABPI of 0.90 or
less or a postexercise ABPI decreasing 20% or more in
at least one leg.6 The second group comprised
patients who were referred because of another vascu-
lar disease or risk factor and also reported a history of
PAD. All patients completed a questionnaire on their
history of cardiovascular disease (based on the Rose
questionnaire),7 risk factors, and current drug use. A
history of PAD was assessed on the basis of the
answers to the Rose questionnaire, the question
“Have you ever been treated for narrowing of the
arteries in one or both legs (surgery or percutaneous
transluminal angioplasty)?”, and the disease history
obtained by the vascular surgeon. 
Patients with known carotid artery stenosis at the
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Table I. Definitions of enrollment diagnoses in the Second Manifestation of ARTerial disease (SMART)
study
Enrollment diagnosis Definition
Carotid stenosis Symptomatic or asymptomatic internal carotid artery stenosis with a diameter reduction of
‡ 50% (peak systolic velocity ‡ 150 cm/s) on at least one side, measured with color
Doppler-assisted duplex scanning
Peripheral arterial disease Resting ABPI ≤ 0.90 or postexercise ABPI decreasing ‡ 20% in at least one leg, with signs 
of intermittent claudication, rest pain, or gangrene/ulcers
Abdominal aortic aneurysm Distal aortic anteroposterior diameter ‡ 3 cm, measured with ultrasonography
Diabetic foot Presence of tissue necrosis or ulceration at the foot in a patient who has diabetes mellitus
Transient ischemic attack According to criteria established by the neurologist
or minor ischemic stroke
Renal artery stenosis Renal artery stenosis with a diameter reduction ‡ 50% on at least one side, measured with 
angiography, with hypertension or renal failure
Angina pectoris Chest pain with or without documented ischemia on the ECG and with documented 
stenoses on the angiography (in practical terms, a patient with indication for percutaneous 
transluminal coronary angioplasty)
Myocardial infarction At least two of the following: (1) chest pain for at least 20 minutes, not disappearing after 
administration of nitrates; (2) ST-elevation > 1 mm in two following leads or a left bundle 
branch block on the ECG; (3) CK level elevation of at least two times the normal value of 
CK and a MB-fraction > 5% of the total CK level
Hyperlipidemia Total cholesterol ‡ 6.5 mmol/L, triglycerides ‡ 2.3 mmol/L, HDL cholesterol ≤ 1.0 
mmol/L, or use of lipid-lowering drugs
Diabetes mellitus types 1 and 2 Fasting plasma glucose level ‡ 7.0 mmol/L, non-fasting serum glucose level ‡ 11.1 
mmol/L, or use of oral antidiabetic drugs or insulin
Hypertension Systolic blood pressure ‡ 160 mm Hg, diastolic blood pressure ‡ 95 mm Hg, or use of 
antihypertensive drugs
Renal insufficiency Plasma creatinine level > 120 m mol/L or microproteinuria > 3 mg per mmol creatinine
ABPI, Ankle brachial pressure index; ECG, electrocardiogram; CK, creatinine kinase; MB, myocardial band; HDL, high density lipoprotein.
time of referral or a history of previous carotid
endarterectomy, stroke, transient ischemic attack, or
amaurosis fugax were excluded from the analysis.
Internal carotid artery stenosis. Color Doppler-
assisted duplex scanning of the carotid arteries was
performed to detect ICAS, which was determined by
means of blood flow velocities. The duplex scans were
performed by well-trained registered vascular technol-
ogists in a certified vascular laboratory. An ICAS was
defined as a peak systolic velocity of more than 150
cm/s, corresponding with a diameter reduction of
50% or more on at least one side.8,9
Cardiovascular risk factors. The height of patients
was measured without shoes by means of a fixed sta-
diometer, and their weight was measured without
heavy clothing by means of standard scales. Body mass
index was calculated as the ratio of weight to height
squared (kg/m2). Blood pressure was recorded nonin-
vasively at the right brachial artery with a semiautomat-
ic oscillometric device in supine position every 4 min-
utes for a total of 25 minutes. Mean blood pressure was
calculated as the average of all obtained measurements.
A venous blood sample was collected after an overnight
fast of at least 8 hours. Plasma total cholesterol and glu-
cose levels were measured with commercial enzymatic
dry chemistry kits (Johnson and Johnson). Smoking
habits, drug use, and history of angina pectoris,
myocardial infarction, and abdominal aortic aneurysm
were derived from the questionnaire and from the dis-
ease history obtained by the treating physician. 
Data analysis. The prevalence of ICAS was
determined in patients who had PAD without known
cerebrovascular disease. Associations between patient
characteristics and ICAS were evaluated by means of
logistic regression analyses (SPSS for Windows 7.5,
SPSS, Chicago, Ill) after continuous variables were
divided in tertiles, because then the results may be
interpreted more easily. Variables that had a signifi-
cance level of 0.25 or less in the univariate analyses
were sequentially entered into a multivariate model
until no remaining candidate variable had a signifi-
cance level of 0.10 or less. 
The proportion of patients in whom the charac-
teristics associated with ICAS were present and the
prevalence of ICAS in these patients were calculated. 
RESULTS
Of the 600 patients in the SMART cohort, 159
patients had PAD and 40 patients had a history of
PAD. Of these, 30 patients were excluded because of
known carotid artery stenosis, history of carotid
endarterectomy, or cerebrovascular symptoms. In
seven patients, duplex scanning was not performed
because of logistic reasons. In total, 162 patients
were included in the analysis. The baseline charac-
teristics of the study population are presented in
Table II. Twenty-three patients (14%) had an ICAS
of 50% or greater on at least one side. Of these, 12
patients had an ICAS of 70% to 99% (two patients
bilateral), and nine patients had an ICAS of 50% to
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Table II. Baseline characteristics of patients with peripheral arterial disease (n = 162)
ICAS ICAS
yes no
n = 23 n = 139
Age (years) 68 (8) 59 (11)
Men (%) 61 65
Smoking, current or past (%) 83 87
Height (cm) 170 (8) 173 (9)
Weight (kg) 70 (12) 78 (15)
Body mass index (kg/m2) 24 (3) 26 (4)
Systolic blood pressure (mm Hg) 151 (17) 148 (18)
Diastolic blood pressure (mm Hg) 74 (9) 80 (10)
Pulse pressure (mm Hg) 78 (16) 68 (16)
Antihypertensive drug use (%) 43 34
Total cholesterol (mmol/L) 6.4 (1.0) 5.9 (1.3)
Lipid-lowering drug use (%) 22 19
Glucose (mmol/L) 7.0 (2.4) 6.8 (2.6)
Insulin or blood sugar-lowering drug use (%) 26 19
Angina pectoris (%) 26 16
Myocardial infarction (%) 17 19
Ankle brachial pressure index* 0.63 (0.17) 0.70 (0.23)
History of abdominal aortic aneurysm (%) 9 8
Values are percentages or means, with standard deviation in parenthesis.
*Lowest ankle brachial pressure index of both legs.
ICAS, Internal carotid artery stenosis.
69% (one patient bilateral) on at least one side. One
patient had an occlusion of the right internal carotid
artery and an ICAS of 70% to 99% on the left side,
and another patient had an occlusion on the right
side and a stenosis less than 30% on the left side.
Results of the univariate logistic regression analy-
sis are shown in Table III. Older age, shorter height,
lower weight, lower body mass index, lower diastolic
blood pressure, higher pulse pressure, higher total
cholesterol level, presence of angina pectoris, and
lower ankle brachial pressure index were associated
with ICAS of 50% or greater at a significance level of
0.25 or less. Being thin appeared to be highly asso-
ciated with ICAS. In stepwise multivariate logistic
regression analysis, age, body weight, and diastolic
blood pressure remained independently associated
with ICAS (Table IV). Adjusting for the use of anti-
hypertensive drugs did not alter the results.
The prevalence of ICAS increased from 14%
(prevalence in all patients studied) to 32% and 50%,
respectively, in patients who had two (21% of the
patients) or three (6% of the patients) of the charac-
teristics described in Table III (Table V). The preva-
lence decreased to 4% and 8%, respectively, in
patients with no or only one of these characteristics. 
DISCUSSION
The prevalence of ICAS of 50% or greater was 14%
in our study population and was independently associ-
ated with age, low body weight, and low diastolic
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Table III. Associations between characteristics and
internal carotid artery stenosis in patients with
peripheral arterial disease, by means of univariate
logistic regression analysis
Odds ratio 95% CI P
Age (years)
≤ 54* 1.0
55 to 66 10.0 1.2 to 83 .03
‡ 67 19.2 2.4 to 152 < .01
Sex (women = 0, men = 1) 0.8 0.3 to 2.0 .67
Smoking, past or current 0.7 0.2 to 2.3 .57
Height (cm)
≤ 168 2.8 0.8 to 9.7 .11
169 to 177 2.7 0.8 to 9.2 .11
‡ 178* 1.0
Weight (kg)
≤ 68 3.3 1.2 to 9.5 .02
69 to 84 0.5 0.1 to 2.0 .29
‡ 85* 1.0
Body mass index (kg/m2)
≤ 23 3.1 1.0 to 10.2 .06
24 to 26 1.8 0.5 to 6.7 .41
‡ 27* 1.0
Systolic blood pressure 
(mm Hg)
≤ 139* 1.0
140 to 156 1.5 0.5 to 4.8 .50
‡ 157 1.6 0.5 to 4.7 .43
Diastolic blood pressure 
(mm Hg)
≤ 75 4.1 1.3 to 13 .02
76 to 83 1.1 0.3 to 4.5 .93
‡ 84* 1.0
Pulse pressure (mm Hg)
≤ 59* 1.0
60 to 73 3.0 0.6 to 15 .17
‡ 74 5.8 1.2 to 28 .03
Antihypertensive drug use 1.5 0.6 to 3.7 .37
Total cholesterol (mmol/L)
≤ 5.4* 1.0
5.5 to 6.5 1.4 0.4 to 4.6 .61
‡ 6.6 2.5 0.8 to 7.8 .11
Lipid-lowering drug use 1.2 0.4 to 3.6 .73
Glucose (mmol/L)
≤ 5.4* 1.0
5.5 to 6.5 0.7 0.2 to 2.1 .49
‡ 6.6 0.9 0.3 to 2.7 .87
Insulin or blood sugar-
lowering drug use 1.5 0.6 to 4.3 .41
Ankle brachial pressure 
index†
≤ 0.58 5.8 1.2 to 28 .03
0.59 to 0.78 5.3 1.1 to 26 .04
‡ 0.79* 1.0
Angina pectoris 1.9 0.7 to 5.3 .23
Myocardial infarction 0.9 0.3 to 2.8 .82
History of abdominal 1.1 0.2 to 5.4 .90
aortic aneurysm
*Reference group
†Lowest ankle brachial pressure index of both legs
Table V. Prevalence of internal carotid artery
stenosis in patients with peripheral arterial disease
according to the number of risk indicators
Number of Proportion Presence of ICAS
risk indicators* of patients yes no Prevalence†
0 35% 2 55 4%
1 38% 5 56 8%
2 21% 11 23 32%
3 6% 5 5 50%
*Age ‡ 67 years, body weight ≤ 68 kg, diastolic blood pressure ≤
75 mm Hg
†Prevalence in total study population is 14%
ICAS, Internal carotid artery stenosis.
Table IV. Characteristics independently associated
with internal carotid artery stenosis in patients with
peripheral arterial disease
Odds ratio 95% CI P
Age ‡ 67 years 3.2 1.1 to 8.8 .03
Weight ≤ 68 kg 4.3 1.5 to 12.2 .01
Diastolic blood pressure 3.0 1.1 to 9.6 .04
≤ 75 mm Hg
blood pressure. In patients with none of these charac-
teristics, the prevalence of ICAS was just 4%. However,
the prevalence becomes markedly higher in patients
with two or three characteristics: 32% and 50%, respec-
tively. These observations may be used to increase the
chance of detecting an ICAS in patients who have
PAD without known cerebrovascular disease.
Results of other studies showed prevalences of
ICAS from 14% to 28% in patients who had PAD.10-
15 The wide range of prevalence of carotid artery
stenosis reported can be explained by the different
definitions and methods used by the investigators to
define the study population and the degree of
carotid stenosis. The duplex scan criteria used for
grading carotid stenosis are especially different. 
We did not have information on the presence of
carotid bruit. Although a carotid bruit does not have
a high sensitivity, it is significantly associated with
ICAS of 50% or greater.11-13 Using information on
carotid bruit might increase the prevalence of
ICAS.16 Adequate assessment of bruits, however,
demands trained and experienced personnel.
Aside from age, low body weight and low dias-
tolic blood pressure were associated independently
with ICAS. As a result of the cross-sectional design
of this study, these parameters have to be regarded
as markers for the presence of ICAS and not as risk
factors for ICAS. The observed high systolic and low
diastolic blood pressure and, therefore, high pulse
pressure may be the result rather than the cause of
the disease process. A more atherosclerotic vascular
system results in stiffer arteries, and such stiffening,
through a variety of mechanisms, tends to raise sys-
tolic blood pressure and lower the diastolic blood
pressure.17-21 In our study, systolic blood pressure
and pulse pressure were positively associated with
ICAS, but did not reach statistical significance in
multivariate analysis, indicating that diastolic blood
pressure is a better predictor.20,21 Obesity is general-
ly accepted as a risk factor for cardiovascular disease.
Surprisingly, in this study low body weight was inde-
pendently associated with the presence of ICAS.
Several studies reported an inverse relationship
between short stature and cardiovascular morbidity
and mortality,21-24 although the evidence is not con-
sistent.25,26 Most of these studies are focused on
body height, whereas in our study, low body weight
was a marker of ICAS independent from height.
Other studies showed a less pronounced or even an
inverse relationship between body mass index and
(cardiovascular) mortality in elderly people.26,29
Other investigators found indicators such as
age,13,15 carotid bruit,11,13,14 and more severe
PAD11,13 to be associated with ICAS. Klop et al
reported that none of the risk factors they investi-
gated (age, gender, history of hypertension, cardiac
disease, diabetes mellitus, hypercholesterolemia,
smoking, and severity of PAD) in 416 patients who
had PAD or abdominal aortic aneurysm had a sig-
nificant relationship with ICAS.10 Unfortunately, in
these studies, risk factor assessment was based on
questionnaires rather than direct measurement.
Some investigators recommended that all patients
who have PAD should undergo duplex scanning of
the carotid arteries, because limiting screening to
patients with characteristics associated with ICAS
would exclude too many patients with steno-
sis.11,13,14 Ahn et al concluded that routine carotid
screening in patients who have PAD can be limited
to patients older than 68 years.15 The clinical conse-
quences of detecting an asymptomatic ICAS, how-
ever, are still limited. Investigators of the
Asymptomatic Carotid Atherosclerosis Study
(ACAS) reported a benefit from carotid endarterec-
tomy in asymptomatic patients who had an ICAS
that was greater than 60%.31 This benefit, however,
has to be interpreted with caution, and the indica-
tion for surgery of asymptomatic ICAS is still a mat-
ter of debate.32-37 Moreover, widespread duplex
screening may result in unnecessary angiography,
which in turn may cause cerebrovascular or other
complications.38 Medical treatment remains the sen-
sible alternative for patients who have asymptomatic
carotid stenosis.36,39 Results are awaited from the
ongoing Asymptomatic Carotid Surgery Trial
(ACST)40,41 or similar trials. Meanwhile, to prevent
widespread screening, the characteristics we found
to be associated with ICAS, ie, age, low body
weight, and low diastolic blood pressure, may be
used in screening programs to increase the likeli-
hood of the presence of an ICAS in patients who
have PAD. These patients may then be entered in
one of the ongoing asymptomatic carotid
endarterectomy trials.
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APPENDIX. PARTICIPANTS IN THE
SMART STUDY GROUP.
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Department of Internal Medicine; Prof B.C.
Eikelboom, MD, PhD, Department of Vascular
Surgery; P.P.Th. de Jaegere, MD, PhD, Department
of Cardiology; L.J. Kappelle, MD, PhD, Department
of Neurology; Prof. A.J. Rabelink, MD, PhD,
Department of Nephrology; and Prof. W.P.Th.M.
Mali, MD, PhD, Department of Radiology, University
Medical Center, Utrecht, The Netherlands.
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